Spark Therapeutics Aktie
Finanztrends
Deine Einschätzung
Was spricht für und gegen Spark Therapeutics in den nächsten Jahren?
Pro
?
M************
?
L*********** I********** f** d** n******* J****
?
A****************
Kontra
?
U****************
?
M****
?
W******* i* V********
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Spark Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| Ligand Pharmaceuticals | -1,54 % | -3,76 % | -7,25 % | 118,80 % | 54,22 % | 316,26 % | 167,06 % |
| United Therapeutics | 0,00 % | -2,02 % | -3,76 % | 84,88 % | 6,74 % | 104,99 % | 194,26 % |
| Ionis Pharmaceuticals Inc. | 2,81 % | -5,96 % | -34,58 % | 21,71 % | -32,02 % | 27,98 % | 47,51 % |
Kommentare
News
London Stock Exchange Group H1 Earnings Call Highlights
Key Points
- Interested in London Stock Exchange Group plc? Here are five stocks we like better.
- LSEG delivered strong first-half results: Organic revenue grew 8.4%, adjusted EBITDA rose 14%
Palantir's Wild Ride: Inside the Stock Wall Street Can't Agree On
Key Points
- Interested in Palantir Technologies Inc.? Here are five stocks we like better.
- Palantir Technologies continues to post exceptional revenue growth, led by U.S. government and commercial
Dollar Tree’s Turnaround Is Starting to Take Root
Key Points
- Interested in Dollar Tree, Inc.? Here are five stocks we like better.
- Dollar Tree's board approved a $2.5 billion share repurchase in July 2026, arriving shortly after activist